0000849146false00008491462025-11-062025-11-06

 ______________________________

 ______________________________

 ______________________________

______________________________

(Address of principal executive offices, including zip code)

_____________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

LifeVantage Corporation (the “Company”) held its fiscal year 2026 annual meeting of stockholders on November 6, 2025 (the “Annual Meeting”). Of the 12,691,009 shares of the Company’s common stock outstanding as of the record date, 9,571,454 shares, or 75.41% were represented at the Annual Meeting either in person or by proxy. The following proposals were submitted to a vote of the Company’s stockholders at the Annual Meeting:

1. To elect the following seven director nominees to the Company’s board of directors to hold office until the Company’s fiscal year 2027 annual meeting of stockholders or until their respective successors are elected and qualified:

2. To approve, on an advisory basis, a resolution approving the compensation of the Company’s named executive officers;

3. To ratify the selection of Deloitte & Touche, LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending June 30, 2026; and

4. To approve an amendment to the 2017 Long-Term Incentive Plan.

The proposals submitted to a vote of the Company’s stockholders at the Annual Meeting are more fully described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on September 19, 2025.

The final voting results of each proposal were as follows:

Proposal 1 – Election of Directors.

The Company’s stockholders elected each of the seven director nominees listed above to the Company’s board of directors (the “Board”) to serve until the Company’s fiscal year 2027 annual meeting of stockholders or until their respective successors are elected and qualified. Votes cast were as follows:

						For						Against									Abstain			Broker Non-Votes
Mr. Rajendran Anbalagan						7,559,064						102,322									36,420			1,873,648
Mr. Michael A. Beindorff						5,494,579						2,169,807									33,420			1,873,648
Mr. Steven R. Fife						7,634,222						31,187									32,397			1,873,648
Mr. Raymond B. Greer						5,715,100						1,949,855									32,851			1,873,648
Mr. Dayton Judd						6,961,169						703,786									32,851			1,873,648
Ms. Cynthia Latham						7,463,640						191,438									42,728			1,873,648
Mr. Darwin K. Lewis						5,640,894						1,999,965									56,947			1,873,648

Proposal 2 – Approval, on an Advisory Basis, of a Resolution Approving the Compensation of the Company’s Named Executive Officers.

The Company’s stockholders approved, on an advisory and non-binding basis, the compensation of the Company’s named executive officers. Votes cast were as follows:

Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm.

The Company’s stockholders ratified the selection of Deloitte & Touche, LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026. Votes cast were as follows:

Proposal 4 – Approval of an Amendment to the Company’s 2017 Long-Term Incentive Plan.

The Company’s stockholders approved the amendment to the Company’s 2017 Long-Term Incentive Plan. Votes cast were as follows:

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.